Cvs Health Advanced Acne Spot Treatment

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the treatment of acne. It is intended for use in patients diagnosed with this condition to help manage and reduce the severity of acne symptoms.

Dosage and Administration

Healthcare professionals are advised to cleanse the skin thoroughly prior to the application of the product. The affected area should be covered with a thin layer of the product one to three times daily.

To minimize the risk of excessive drying of the skin, it is recommended to initiate treatment with one application daily. Based on the patient's response and as directed by a physician, the frequency may be gradually increased to two or three times daily.

In cases where bothersome dryness or peeling occurs, the application frequency should be reduced to once a day or every other day to alleviate these symptoms.

Contraindications

Use is contraindicated in patients with a history of eye contact, as exposure may lead to irritation. In the event of contact with the eyes, it is essential to flush thoroughly with water to mitigate potential adverse effects. No other contraindications have been identified.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from sparks, heat, or open flames to prevent fire hazards.

In the event of accidental ingestion, it is imperative to seek immediate medical assistance or contact a Poison Control Center. Additionally, care should be taken to avoid contact with the eyes. Should contact occur, it is essential to flush the eyes thoroughly with water to mitigate potential irritation or injury.

No specific laboratory tests are recommended for monitoring during the use of this product. However, healthcare professionals should remain vigilant for any adverse reactions or complications that may arise from its use.

Side Effects

Patients should be aware that the product is for external use only. It is important to note that the formulation is flammable; therefore, it should be kept away from sparks, heat, or open flames to prevent any potential hazards.

No additional adverse reactions have been reported in clinical trials or postmarketing experiences.

Drug Interactions

Concurrent use of topical acne medications may increase the risk of skin irritation and dryness. It is advisable to limit the use of topical acne treatments to one at a time to minimize the potential for adverse effects. If irritation occurs, the patient should discontinue the use of additional topical acne medications and consult a healthcare professional for further guidance.

Packaging & NDC

Below are the non-prescription pack sizes of Cvs Health Advanced Acne Spot Treatment (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of CVS Health Advanced Acne Spot Treatment in geriatric patients. The prescribing information does not provide guidance on dosage adjustments, safety concerns, or special precautions for elderly patients. Therefore, healthcare providers should exercise caution when considering this treatment for patients aged 65 and older, as the absence of data necessitates careful monitoring and individualized assessment of treatment risks and benefits in this population.

Pregnancy

Safety during pregnancy has not been established for this product. It is not recommended for use during pregnancy due to potential risks to the fetus. There may be risks associated with the use of salicylic acid during pregnancy; therefore, it is essential for pregnant patients to consult a healthcare provider for personalized advice.

Dosage adjustments may be necessary for pregnant individuals, and medical guidance should be sought to determine the appropriate course of action. Pregnant women should avoid using this product unless directed by a healthcare professional to mitigate any potential risks.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the lack of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function is advisable to ensure patient safety and therapeutic efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and consider general principles of management for suspected cases of drug overdosage.

Recommended Actions In the event of an overdosage, it is essential to assess the patient's clinical status promptly. Healthcare providers should initiate supportive care and monitor vital signs closely. The management of overdosage may include the following steps:

1. Assessment: Evaluate the patient's symptoms and obtain a detailed history of the substance involved, including the amount and time of ingestion.

2. Supportive Care: Provide symptomatic treatment as necessary, which may include intravenous fluids, oxygen supplementation, or other interventions based on the patient's condition.

3. Consultation: Engage with a poison control center or a medical toxicologist for guidance on specific management strategies tailored to the substance involved.

Potential Symptoms While specific symptoms of overdosage are not detailed, healthcare professionals should remain vigilant for common signs that may indicate an adverse reaction or toxicity. These may include, but are not limited to, altered mental status, respiratory distress, cardiovascular instability, or gastrointestinal disturbances.

In summary, due to the lack of specific overdosage information, healthcare professionals should rely on established protocols for managing suspected overdosage cases, ensuring that patient safety remains the top priority.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the medication is swallowed. It is crucial to emphasize the importance of avoiding contact with the eyes. In the event of accidental contact, patients should be instructed to flush the eyes thoroughly with water.

Patients should be made aware that using this medication in conjunction with other topical acne treatments may increase the likelihood of skin irritation and dryness. Therefore, it is recommended that patients use only one topical acne medication at a time to minimize the risk of irritation.

Reinforcing these points will help ensure that patients use the medication safely and effectively while being aware of potential risks and necessary actions in case of accidental exposure.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is important to note that the product may stain some fabrics, and care should be taken to avoid contact with such materials.

For optimal storage, the product should be kept at controlled room temperature. It is recommended to store the product in a cool, dry place, away from direct sunlight and moisture. Special handling precautions should be observed to prevent any potential staining of surfaces or materials.

Additional Clinical Information

The medication is administered topically, with a recommended application of a thin layer covering the entire affected area one to three times daily. Patients should begin with one application daily and may gradually increase to two or three times daily as needed or as directed by a healthcare professional.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Cvs Health Advanced Acne Spot Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)